- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03559452
Muscle Damage and Disuse Atrophy
September 20, 2021 updated by: University of Exeter
In Young Healthy Males and Females, What is the Effect of Prior Eccentric Exercise on Thigh Muscle Atrophy During One Week of Leg Disuse Compared to no Prior Exercise?
Limb injury generally requires a period of recovery during which time the limb is often immobilised (e.g. with a cast or brace) resulting in a rapid loss of skeletal muscle.
Despite the importance of muscle loss during injury, our understanding of how it occurs is incomplete.
Several factors are likely to contribute, including a lack of muscle contraction and injury induced inflammation.
In this study, the investigators will recruit healthy volunteers who will spend 7 days in a knee brace to replicate leg immobilisation.
Prior to immobilisation, half of the participants will perform a single session of strenuous resistance exercise which is known to cause muscle damage and initiate an inflammatory response.
This is designed to replicate the muscle damage and inflammation that occurs with injury.
The remaining half of participants will not perform this exercise, allowing us to look at the additive effect of muscle damage and inflammation on muscle loss with immobilisation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Devon
-
Exeter, Devon, United Kingdom, EX1 2LU
- University of Exeter
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 18 - 40
- BMI between 18 and 27
- Healthy, recreationally active, non smoker
Exclusion Criteria:
- Non-removable metallic implants (including heart pacemaker, cochlear implants, medication pumps, surgical clips, plates or screws) or claustrophobia
- Use of nutritional supplements
- Chronic use of over the counter medication
- Any diagnosed metabolic disease (e.g. type 1 or 2 Diabetes).
- Any diagnosed cardiovascular disease or hypertension.
- Anyone with previous motor disorders. Anyone with a current musculoskeletal injury that may impair their use of crutches.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Immobilisation without prior exercise
|
|
|
Experimental: Muscle damage
300 bilateral knee extensor eccentric contraction performed immediately prior to immobilisation
|
300 eccentric contractions of the knee extensors
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in thigh muscle volume from pre-immobilisation
Time Frame: After 2 days of immobilisation
|
The volume of the muscles comprising the thigh after 2 days of immobilisation will be compared to pre-immobilisation values.
This will be measured using MRI.
|
After 2 days of immobilisation
|
|
Change in thigh muscle volume from pre-immobilisation
Time Frame: After 7 days of immobilisation
|
The volume of the muscles comprising the thigh after 7 days of immobilisation will be compared to pre-immobilisation values, and values obtained after 2 days of immobilisation.
This will be measured using MRI.
|
After 7 days of immobilisation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in unilateral knee extensor 1 repetition maximum
Time Frame: After 7 days of immobilisation
|
Unilateral knee extensor 1 repetition maximum will be measured before and after 7 days of single leg immobilisation using a weight stack leg extension machine
|
After 7 days of immobilisation
|
|
Change in unilateral knee extensor maximal voluntary torque production
Time Frame: After 7 days of immobilisation
|
Unilateral knee extensor maximal voluntary torque production will be measured before and after 7 days of single leg immobilisation using an isokinetic dynamometer.
|
After 7 days of immobilisation
|
|
Change in unilateral knee extensor isokinetic total work
Time Frame: After 7 days of immobilisation
|
Unilateral knee extensor total isokinetic work after 30 consecutive contractions will be measured before and after 7 days of single leg immobilisation using an isokinetic dynamometer.
|
After 7 days of immobilisation
|
|
Muscle protein synthesis assessed using the stable isotope Deuterium Oxide
Time Frame: After 2 days of immobilisation
|
The enrichment of deuterated alanine (from the deuterium oxide heavy water stable isotope tracer) in vastus lateralis biopsy samples will be measured relative to the non-deuterated alanine.
The change between pre-immobilisation and 2 days of immobilisation will be used to calculated a fractional synthetic rate (% day).
|
After 2 days of immobilisation
|
|
Muscle protein synthesis assessed using the stable isotope Deuterium Oxide
Time Frame: After 7 days of immobilisation
|
The enrichment of deuterated alanine (from the deuterium oxide heavy water stable isotope tracer) in vastus lateralis biopsy samples will be measured relative to the non-deuterated alanine.
The change between pre-immobilisation and 7 days of immobilisation will be used to calculated a fractional synthetic rate (% day).
|
After 7 days of immobilisation
|
|
Change in skeletal muscle gene expression
Time Frame: After 2 days of immobilisation
|
Skeletal muscle gene expression will be measured before and after 2 days of single leg immobilisation.
|
After 2 days of immobilisation
|
|
Change in skeletal muscle gene expression
Time Frame: After 7 days of immobilisation
|
Skeletal muscle gene expression will be measured before and after 7 days of single leg immobilisation.
|
After 7 days of immobilisation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2018
Primary Completion (Actual)
October 31, 2019
Study Completion (Actual)
October 31, 2019
Study Registration Dates
First Submitted
May 31, 2018
First Submitted That Met QC Criteria
June 13, 2018
First Posted (Actual)
June 18, 2018
Study Record Updates
Last Update Posted (Actual)
September 27, 2021
Last Update Submitted That Met QC Criteria
September 20, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 171206/B/08
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Disuse Atrophy
-
United States Army Research Institute of Environmental...RecruitingMuscle Disuse | Muscle Disuse AtrophyUnited States
-
United States Army Research Institute of Environmental...CompletedMuscular Disorders, Atrophic | Muscle Atrophy | Disuse Atrophy | Atrophy, Disuse | Disuse Atrophy Muscle of ThighUnited States
-
McGill UniversityCompletedMuscle Atrophy | Muscle Disuse AtrophyCanada
-
McMaster UniversityTerminatedSarcopenia | Muscle Atrophy | Muscle Disuse AtrophyCanada
-
McMaster UniversityCompletedMuscle Atrophy | Disuse Atrophy (Muscle) of Lower LegCanada
-
University of BirminghamCompletedMuscle Disuse AtrophyUnited Kingdom
-
Texas Christian UniversityRecruiting
-
McMaster UniversityActive, not recruitingHealthy | Muscle Disuse AtrophyCanada
-
McMaster UniversityMyos CorporationCompletedNutrition, Healthy | Muscle Disuse AtrophyCanada
-
Bispebjerg HospitalRecruitingMuscle Function | Neuromuscular Electrical Stimulation | Disuse Atrophy (Muscle) of Lower Extremities | Myofibrillar Protein SynthesisDenmark
Clinical Trials on Eccentric exercise
-
University of MalagaUnknownRotator Cuff Tendinopathy
-
Oslo University HospitalUniversity of OsloCompleted
-
Chinese Culture UniversityCompletedAcute Muscle Damage Following Resistance ExerciseTaiwan
-
Queen Margaret UniversityUnknownTendinopathy | Achilles TendonUnited Kingdom
-
Universidad Europea de MadridCompletedAchilles Tendinopathy | Diastasis RectiSpain
-
Utah State UniversityNot yet recruitingBlood Flow Restriction
-
Universidad Europea de MadridCompletedTendinopathy | Achilles TendonSpain
-
University of ValenciaRecruitingPatellar TendinopathySpain
-
New York Institute of TechnologyRecruitingHypermobility SyndromeUnited States
-
Centre Hospitalier Universitaire de BesanconUnknownVentilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD (CONvEX)Chronic Obstructive Pulmonary Disease SevereFrance